|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
SKELETAL MUSCLE AND EXERCISE |
1 Department of Anaesthesiology, Human Integrative Physiology Laboratory, and General Clinical Research Center, Mayo Clinic, Rochester, MN 55905, USA
2 Department of Kinesiology, University of Wisconsin, Madison, WI 53706, USA
In older humans, infusions of endothelial agonists suggest endothelial dysfunction, due in part to less nitric oxide (NO)- and prostaglandin (PG)-mediated vasodilatation, and a shift toward PG-mediated vasoconstriction. Ageing can also be associated with lower exercise blood flow (exercise hyperaemia), but the vascular mechanisms mediating this remain unknown. Notably, in young adults, inhibition of NO and PGs during exercise decreases exercise hyperaemia by
20 and
12%, respectively. We tested our first hypothesis that in older humans inhibition of NO would decrease hyperaemia, but that inhibition of PGs would increase hyperaemia by blocking vasoconstrictor PGs. Fifteen older subjects (65 ± 3 years) performed dynamic forearm exercise for 20 min (20 contractions min1). Forearm blood flow (FBF) was measured beat-to-beat with Doppler ultrasound, while saline or drugs were infused sequentially via brachial artery catheter in the exercising forearm. After achieving steady-state exercise, L-NAME (25 mg) was infused over 5 min to inhibit NO synthase. After a further 2 min of exercise (saline), ketorolac (6 mg) was infused over 5 min to inhibit PGs, followed by a futher 3 min of exercise with saline. Drug order was reversed in seven subjects. L-NAME reduced steady-state exercise hyperaemia by 12 ± 3% in older subjects (P < 0.01), whereas ketorolac had no net effect on blood flow (3 ± 6%, P > 0.4). The effects of L-NAME and ketorolac were independent of drug order. By comparing these results with our previous results in young adults, we tested our second hypothesis that in older humans inhibition of NO or PGs would have less impact on exercise hyperaemia due to less vasodilatation from these signals. Our results suggest that, compared with young adults, in older humans the relative contribution of NO to exercise hyperaemia is reduced
45% (22 ± 4 versus 12 ± 3%), but the role of PG in mediating vasodilatation is lost in ageing human skeletal muscle. Lower exercise hyperaemia in older humans may be mediated in part by less NO- and PG-mediated vasodilatation during exercise.
(Received 5 November 2006;
accepted after revision 30 November 2006;
first published online 7 December 2006)
Corresponding author W. G. Schrage: Department of Kinesiology, 1149A Natatorium, University of Wisconsin, Madison, WI 53706, USA. Email: wschrage{at}education.wisc.edu
This article has been cited by other articles:
![]() |
J. P. Fisher, S. Ogoh, C. N. Young, P. B. Raven, and P. J. Fadel Regulation of middle cerebral artery blood velocity during dynamic exercise in humans: influence of aging J Appl Physiol, July 1, 2008; 105(1): 266 - 273. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. R. Chiappa, B. T. Roseguini, P. J.C. Vieira, C. N. Alves, A. Tavares, E. R. Winkelmann, E. L. Ferlin, R. Stein, and J. P. Ribeiro Inspiratory Muscle Training Improves Blood Flow to Resting and Exercising Limbs in Patients With Chronic Heart Failure J. Am. Coll. Cardiol., April 29, 2008; 51(17): 1663 - 1671. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. Carlson, B. S. Kirby, W. F. Voyles, and F. A. Dinenno Evidence for impaired skeletal muscle contraction-induced rapid vasodilation in aging humans Am J Physiol Heart Circ Physiol, April 1, 2008; 294(4): H1963 - H1970. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |